Home/Filings/4/0001214659-22-004370
4//SEC Filing

Bhavnagri Veer 4

Accession 0001214659-22-004370

CIK 0001737287other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 5:49 PM ET

Size

6.8 KB

Accession

0001214659-22-004370

Insider Transaction Report

Form 4
Period: 2022-03-23
Bhavnagri Veer
General Counsel
Transactions
  • Award

    Common Stock

    2022-03-23+175,438589,279 total
  • Award

    Stock Option (Right to Buy)

    2022-03-23+272,435272,435 total
    Exercise: $9.69Exp: 2032-03-23Common Stock (272,435 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001808980

Filing Metadata

Form type
4
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 5:49 PM ET
Size
6.8 KB